WASHINGTON, D.C.– The U.S. National Security Commission on Emerging Biotechnology issued its first report since its creation through the National Defense Authorization Act of FY2022. The bipartisan ...

Biotechnology leader Biocon is fully integrating Biocon Biologics, valuing it at $5.5 billion. The merger involves share ...

Trust is often a major barrier to companies integrating AI tools. Learn how better data governance can improve confidence.

Using biological agents as weapons is illegal, but an organism that scientists lawfully use for genuine research could be repurposed for an attack. Therefore, what is banned depends on what an actor ...

The National Security Commission on Emerging Biotechnology (NSCEB) delivered its major report and action plan to Congress in early April with a blunt message: the world is entering a new age driven by ...

Indiana shows high potential for the state to become the premiere destination to research, commercialize, scale biotechnology ...

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

Lixte Biotechnology Holdings Inc. (NASDAQ:LIXT) saw its stock drop 11.5% on Tuesday after the company announced the ...

Opinions expressed by Entrepreneur contributors are their own. The past three years have changed nearly every industry. Where business used to be conducted in person, in offices and laboratories, the ...

Medical and legal authorities spoke about the ethics and future of biotechnology at a Friday panel hosted by the Program on Science, Technology, and Society at the Harvard Kennedy School. As part of ...